MedTrace Logo

ECG Belt for CRT Response

NCT03504020 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 498

Last updated 2023-02-03

Study results available
· View outcomes & findings →

Summary

The purpose of this clinical study is to compare ECG Belt Research System managed cardiac resynchronization therapy (CRT) patients and a control CRT group with respect to left ventricular (LV) remodeling.

Conditions

Interventions

DEVICE

ECG Belt Research System

The ECG Belt Research System is used to identify the best vector and programming parameters.

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • ECG Belt for CRT Response Clinical Research Specialist · Medtronic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-13
Primary Completion
2022-01-07
Completion
2022-04-20
FDA Device
Yes

Countries

  • United States
  • Belgium
  • Canada
  • Denmark
  • Italy
  • Netherlands
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03504020 on ClinicalTrials.gov